Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Select market-stage ATMPs price in the U.S. as of 2016

This statistic shows the price of select market-stage ATMPs, as of September 2016. At that moment, the price of ex-vivo gene therapy Strimvelis stood at 665,000 U.S. dollars.

Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

Worldwide

Survey time period

as of September 2016

Supplementary notes

* Mean value.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cell and gene therapy"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.